Zeitschrift für Rheumatologie
-
This study aimed to assess the relative efficacy and tolerability of every other week (q2w) dosing of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis (RA). ⋯ Sarilumab 150 and 200 mg are efficacious treatments for active RA and are well tolerated.